Status:
UNKNOWN
Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Centers for Disease Control and Prevention
Harborview Injury Prevention and Research Center
Conditions:
Opioid Use
Pain, Postoperative
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will enroll 100 participants using a randomized control trial design to implement and evaluate an individualized opioid taper program supporting rural Primary Care Physicians (PCPs) ...
Detailed Description
This study explores the feasibility, efficacy, and potential sustainability of a collaborative pain care/opioid taper strategy for patients discharged to a rural PCP practice on opioids after hospital...
Eligibility Criteria
Inclusion
- Must be at least 18 years old
- Injury Severity Score of 9 or greater
- Resident of Washington state
- Will be discharged to a rural zip code outside of king county.
- Glasgow Coma Score of 15
- Able to read, speak, and write English or Spanish.
- Has an identifiable PCP or willing to accept referral to a local Federally Qualified Health Center (FQHC)
- Has an insurer included in the All Payer Claims Database
- Planned to be discharged on opioid medication
- Planned to be discharged back to the community
Exclusion
- Less than 18 years old
- Injury Severity Score less than 9
- Patient is in judicial custody
- Resident of a state other than Washington
- Will not be discharged to a rural zip code outside of king county.
- Evidence of OUD diagnosis (including using heroin or other illicit opioids in the past month, a DSM-5 OUD diagnosis, or evidence of taking methadone, buprenorphine, or naltrexone).
- Currently in cancer treatment or enrolled in palliative or hospice care
- Residing in a nursing home or assisted living facility
- Using any implanted device for pain control
- Self-report of heroin or other illicit opioid use in the past month
- Psychotic symptoms, psychiatric hospitalization or suicide attempts in the past year (including current admission).
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04275258
Start Date
June 1 2020
End Date
January 31 2022
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98195